文献速递冠心病外科

EuroSCORE II 在2022年仍能可靠预测心脏手术死亡率吗?一项回顾性研究

Is EuroSCORE II still a reliable predictor for cardiac surgery mortality in 2022? A retrospective study study.
PubMed 文献 · Eur J Cardiothorac Surg · 2022-01-01

该回顾性队列研究纳入意大利米兰Monzino心脏中心2016年1月至2022年5月接受心脏手术的4034例患者,评估EuroSCORE II对30天院内死亡率的预测能力。EuroSCORE II的AUC为0.834,区分度良好;但择期手术中极低评分高估死亡率,急诊手术中评分>10则大幅低估死亡率。作者认为EuroSCORE II似乎不是可靠的死亡风险预测工具,尤其在高危患者中。

要点

  • EuroSCORE II预测30天院内死亡率的AUC为0.834,区分度良好。
  • 择期手术中极低EuroSCORE II值高估了观察死亡率。
  • 急诊手术中EuroSCORE II值>10大幅低估了观察死亡率。

核心结论

  • 作者认为EuroSCORE II似乎不是可靠的死亡风险预测工具,尤其在高危患者中。

研究设计与样本

  • 回顾性队列研究,纳入意大利米兰Monzino心脏中心心脏外科2016年1月至2022年5月接受心脏手术的全部患者,共4034例(平均年龄65.1岁,68%为男性),其中674例(16.7%)接受孤立冠状动脉旁路移植术。
  • 采用受试者工作特征曲线及曲线下面积评估EuroSCORE II的区分度,并用校准图评估模型预测与观察结局的一致性。

主要发现

  • EuroSCORE II预测30天院内死亡率的AUC为0.834。
  • 择期手术中,极低的EuroSCORE II值高估了观察死亡率。
  • 急诊手术中,EuroSCORE II值>10大幅低估了观察死亡率。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The European System for Cardiac Operation Risk Evaluation II (EuroSCORE II) is the most common tool used to evaluate the perioperative risk of mortality after cardiac surgery in Europe, and its use is currently recommended by the relevant guidelines. However, recently, its role has been questioned: Several papers have suggested that these algorithms may no longer be adequate for risk prediction due to an overestimation of adult cardiac surgical risk. Our goal was to validate the EuroSCORE II in the prediction of 30-day in-hospital mortality in patients undergoing open cardiac surgery in a high-volume hospital. METHODS: In this retrospective cohort study, we included all patients who underwent cardiac surgery from January 2016 to May 2022 within the departments of cardiac surgery of the Monzino Cardiology Centre in Milan, Italy. We evaluated the discrimination power of the EuroSCORE II by using the receiver operating characteristic curve and the corresponding area under the curve. We performed calibration plots to assess the concordance between the model's prediction and the observed outcomes. RESULTS: A total of 4,034 patients were included (mean age = 65.1 years; 68% males), of which 674 (16.7%) underwent isolated coronary artery bypass grafting. The EuroSCORE II showed a good discrimination power in predicting 30-day in-hospital mortality (area under the curve = 0.834). However, for interventions performed in an elective setting, very low values of the EuroSCORE II overestimated the observed mortality, whereas for interventions performed in an emergency setting, EuroSCORE II values above 10 extensively underestimated the observed mortality. CONCLUSIONS: Our study suggests that the EuroSCORE II seems not to be a reliable score in estimating the true risk of death, especially in high-risk patients.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Mastroiacovo G, Bonomi A, Ludergnani M, et al. Is EuroSCORE II still a reliable predictor for cardiac surgery mortality in 2022? A retrospective study study. Eur J Cardiothorac Surg. 2022. PMID: 37669150. doi:10.1093/ejcts/ezad294

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。